
Eupace-L Tablet ER
Marketer
Kardic Kare
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Eupace-L Tablet ER
Extended-release Metoprolol (similar to Eupace-L Tablet ER) is a beta-blocker medication employed in managing hypertension, angina pectoris, and cardiac arrhythmias. This drug also aids in migraine prophylaxis and reducing the risk of future myocardial infarction and cerebrovascular events. Dosage and administration frequency are tailored to individual needs and condition severity; it can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefit may take several weeks to manifest, and continuous use may be necessary long-term, even with symptom resolution, as discontinuation can exacerbate underlying conditions. Common, generally mild, adverse effects encompass fatigue, cephalalgia, depressive symptoms, diarrhea, dermatological reactions, bradycardia, dizziness, and nausea. Less frequent side effects include dyspnea and hypotension. Gradual dose escalation minimizes adverse event likelihood. Patients experiencing persistent or bothersome side effects should seek medical attention. Pre-existing hepatic impairment, bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension warrant physician consultation before initiating treatment. Similarly, pregnant or lactating individuals should discuss use with their healthcare provider. Regular blood pressure monitoring is essential to assess treatment effectiveness. Alcohol consumption should be limited due to the potential for increased side effect occurrence. Always consult a physician to determine suitability.
Primary Ingredients of Eupace-L Tablet ER
No text provided to rephrase.
Uses of Eupace-L Tablet ER
Managing angina pectoris (chest pain of cardiac origin) | Cardiac arrhythmia management | Mitigation of myocardial infarction | Hypertension (high blood pressure) therapy | Migraine prophylaxis
Major Benefits of Eupace-L Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Eupace-L Tablet ER. The tablet should be swallowed whole; do not chew, crush, or divide it. While you can take it with or without food, consistent timing is recommended. Limit consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and fatty meats, when taking Eupace-L Tablet ER.
Common Side effects of Eupace-L Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Eupace-L Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eupace-L Extended Release Tablets may be consumed with or without food, though consistent timing is recommended. Limit consumption of Eupace-L Extended Release Tablets with meals high in fat, including those containing olive oil, nuts and seeds (particularly Brazil nuts), dark chocolate, butter, and red meat.
How Eupace-L Tablet ER works:
Extended-release Eupace-L tablets are a cardioselective beta-adrenergic blocking agent. Their mechanism of action involves reducing heart rate and improving the heart's overall pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Combining Eupace-L Tablet ER and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Eupace-L tablets might pose pregnancy risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Eupace-L tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Eupace-L tablets can reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Eupace-L tablets are considered safe for use in individuals with kidney impairment. No alteration of the Eupace-L extended-release tablet dosage is necessary.
LiverCAUTION
Extended-release Eupace-L tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eupace-L Tablet ER :
Should you forget a dose of Eupace-L Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eupace-L Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
